IDEX (NYSE:IEX) Stock Price Expected to Rise, Oppenheimer Analyst Says

Key Points

• Oppenheimer raised its IDEX price target to $275 from $270 and maintained an “outperform” rating, implying 17.19% potential upside. Analysts overall give the stock a “Moderate Buy” rating with an average target of $261.09.
• IDEX recently exceeded quarterly expectations, reporting $2.32 in EPS versus the $2.11 consensus and revenue of $920.6 million, up 6.4% year over year.
• The stock traded at $234.66, near its 52-week high of $243.80, while institutional investors own 97.96% of outstanding shares.

IDEX (NYSE:IEX - Get Free Report) had its price objective boosted by equities researchers at Oppenheimer from $270.00 to $275.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has an "outperform" rating on the industrial products company's stock. Oppenheimer's target price would suggest a potential upside of 17.19% from the company's current price.

Several other equities analysts have also recently commented on IEX. DA Davidson upped their target price on shares of IDEX from $230.00 to $240.00 and gave the company a "neutral" rating in a research note on Thursday, August 6th. Weiss Ratings upgraded shares of IDEX from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday, July 30th. KeyCorp upgraded shares of IDEX to a "hold" rating in a research report on Monday, October 12th. Mizuho upgraded shares of IDEX from a "neutral" rating to an "outperform" rating and boosted their price objective for the stock from $210.00 to $280.00 in a report on Tuesday, August 11th. Finally, Vertical Research initiated coverage on shares of IDEX in a research report on Tuesday, September 8th. They set a "buy" rating and a $250.00 price objective for the company. Nine investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, IDEX currently has an average rating of "Moderate Buy" and an average target price of $261.09.

IDEX Stock Performance

NYSE IEX traded up $1.50 during trading on Wednesday, hitting $234.66. The company's stock had a trading volume of 227,997 shares, compared to its average volume of 727,353. The company has a quick ratio of 2.15, a current ratio of 3.05 and a debt-to-equity ratio of 0.46. The firm has a 50 day moving average price of $230.47 and a 200 day moving average price of $221.44. The firm has a market cap of $17.30 billion, a P/E ratio of 33.71, a price-to-earnings-growth ratio of 2.65 and a beta of 0.97. IDEX has a 52 week low of $160.60 and a 52 week high of $243.80.

IDEX (NYSE:IEX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, topping analysts' consensus estimates of $2.11 by $0.21. The company had revenue of $920.60 million during the quarter, compared to analyst estimates of $905.38 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%. The company's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company earned $2.07 earnings per share. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. Equities research analysts forecast that IDEX will post 8.83 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CAO Lisa Anderson sold 385 shares of the firm's stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total value of $91,857.15. Following the completion of the transaction, the chief accounting officer directly owned 4,327 shares of the company's stock, valued at $1,032,378.93. This trade represents a 8.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.50% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On IDEX

Several institutional investors and hedge funds have recently bought and sold shares of IEX. BlackRock Inc. acquired a new position in shares of IDEX during the second quarter valued at $1,301,393,000. Primecap Management Co. CA acquired a new stake in IDEX in the second quarter worth about $748,951,000. Amundi increased its position in IDEX by 19.6% in the second quarter. Amundi now owns 1,458,979 shares of the industrial products company's stock worth $331,017,000 after purchasing an additional 239,579 shares during the period. Alyeska Investment Group L.P. raised its holdings in IDEX by 101.4% during the 2nd quarter. Alyeska Investment Group L.P. now owns 1,042,703 shares of the industrial products company's stock worth $236,641,000 after purchasing an additional 525,048 shares during the last quarter. Finally, Bank of America Corp DE raised its holdings in IDEX by 215.0% during the 1st quarter. Bank of America Corp DE now owns 1,094,101 shares of the industrial products company's stock worth $207,387,000 after purchasing an additional 746,732 shares during the last quarter. Institutional investors own 97.96% of the company's stock.

About IDEX

IDEX Corporation is an industrial manufacturing company headquartered in Lake Forest, Illinois. The company designs and produces engineered products and technologies used to move, control, measure and apply fluids, as well as equipment used in fire and safety applications.

IDEX operates through businesses serving fluid and metering technologies, health and science technologies, and fire and safety markets. Its products include pumps, valves, flow meters, compressors, dispensing equipment, precision fluidics components and systems, fire pumps, rescue tools and other specialized equipment.

The company serves a broad range of industries, including healthcare, life sciences, water and wastewater, chemical processing, energy, food and beverage, agriculture, industrial manufacturing and municipal fire protection.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.